Botox FDA Issues Fraud Alert to U.S. Health Care Practitioners

Los Angeles, California (PRWEB) April 26, 2013

On April 26, 2013, the Food and Drug Administration issued an alert on its website to all health care practitioners that fraudulent version of the drug Botox, manufactured by Allergan, Inc. are being sold to medical practices in the U.S. (go to: goo.gl/iKRXI). Botox has FDA approval to treat migraine headaches, overactive bladders, hyperhidrosis (underarm sweating), and wrinkles.

"It really is an ongoing battle that the FDA is fighting against these counterfeiters, says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. It was only a few months ago that the FDA released a list of physicians that had purchased unapproved Botox from a Canadian pharmacy.

According to the alert, a company operating under numerous aliases including Onlinebotox and OnlineBotoxPharmacy is placing vials labeled as foreign manufactured Botox into counterfeit outside cartons. Despite the internet-related names the company was not selling the counterfeit drug online but was sending mass faxes to solicit sales from medical offices.

Importantly, the FDA noted that only authentic Allergan-manufactured and FDA-approved Botox can be considered safe and effective for its approved uses. Even legitimately produced foreign Botox is not FDA approved for sale in the U.S.

Given that the FDA issued a list of medical providers that purchased unapproved Botox, it is apparent that consumers cannot always rely on others to protect their safety, says Dr. Ourian. Thats why I created a six-point Botox checklist for anyone interested in getting a Botox treatment.

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juv

Faster Wound Care for Diabetic Foot Ulcers: FDA-registration of New Non-prescription Terrasil Wound Care Ointment May Be Important News for 16 million diabetics in U.S.

Woonsocket, RI (PRWEB) June 17, 2013

According to Centers for Disease Control and Prevention (CDC) nearly 30 million people in the U.S. have diabetes. Diabetic foot ulcers are a major complication resulting from diabetes. They occur in approximately 15% of diabetics and precede 84% of all lower leg amputations. Diabetic foot ulcers and related problems cause 20 percent of the nearly 3 million hospitalizations related to diabetes every year. Due to poor circulation in diabetic patients, diabetic chronic wounds heal very slowly and often remain for years as skin ulcers. To control infection and prevent amputation, non-healing chronic wounds require expensive treatments that can cost thousands of dollars. According to the American Diabetes Association, the average cost of healing a single foot ulcer is $ 8,000, that of an infected ulcer is $ 17,000, and that of a major amputation is $ 45,000. But, now there may be an effective and substantially lower-cost alternative.

NEW FDA-REGISTERED WOUND CARE OINTMENT

A new, non-prescription ointment was recently registered with the U.S. Food and Drug Administration (FDA) for distribution in the U.S. It may provide a very low cost alternative for treatment of diabetic foot ulcers and other chronic wounds and traumatic wounds.

Developed and manufactured by Aidance Skincare, a Rhode Island company, their Wound Care Ointment is sold direct to consumers under the brand name Terrasil. During development of the wound care formulation, clinical studies in 2010 and 2011 with 192 patients showed that the ointment was able to heal chronic wounds up to 3.7-times (370%) faster than conventional treatment. Normally, a 15-20% clinical improvement is noteworthy, so more than 300% is extraordinary.

Since the products introduction in October 2012, it has been distributed to hospitals throughout the U.S. By March, Dr. Thomas Serena, MD - one of the worlds top wound care experts - was so impressed with the ointments effectiveness that he initiated a multi-center case study program to document the formulations ability to heal diabetic foot ulcers faster. Physicians and nurses at hospitals, wound care centers and medical offices across the U.S. have demonstrate the powerful efficacy of Terrasil Wound Care & Antiseptic Ointment to control bioburden and support healing 2-4 times faster than comparative treatment options.

Clinical evaluations are currently being performed in 18 hospitals in the U.S., with initial case studies documenting effective control of infection and accelerated healing of even the hardest-to-heal chronic wounds. In addition, in-vitro laboratory tests comparing the companys Wound Care Ointment to Bacitracin, Triple Antibiotic Ointment and several silver gels, showed that the Terrasil formulation killed bacteria up to 21-times (21X) more efficiently and prevented regrowth of the bacteria. This is important because bacterial invasion of chronic wounds, referred to as bioburden, is a major inhibitor of healing.

HELPS DOCTORS HEAL CHRONIC WOUNDS

Dr. Jeffrey Niezgoda, MD, a nationally-prominent wound specialist said: Terrasil is a novel wound ointment that has the potential to provide significant positive impact on one of the primary impediments to healing in chronic wounds: wound bioburden. It is easy to use and well tolerated by patients with all types of non-healing wounds and should be considered as a primary topical agent.

Dr. Brock Liden, DPM, a podiatric researcher and frequent speaker at conferences said: Terrasil Wound Care & Antiseptic Ointment is a new, unique topical cream that has proven to be very effective treating recalcitrant wounds. It has provided a dual-prong benefit for our patients, by resolving infections that did not respond to traditional topical silver dressing - even outperforming oral therapies - and by being effective at epithelizing and closing wounds. This ointment provides the doctor with a new tool that is effective against both easy-to-treat wounds and complicated, difficult-to-heal wounds.

Available in a 14-gram (0.5 ounce) and 44-gram (1.5 ounce) container, the wound care ointment costs between $ 24 and $ 57. The Terrasil ointment provides three critical functions: providing a barrier protection for wounds (especially chronic wounds), reducing the chance of infection, and supporting healing. The wound care ointments are formulated with a patented mineral complex, active ingredients, organic extracts and compounds. These mixtures produce a synergistic effect that provides outstanding support for accelerated natural healing of diabetic foot ulcers and other types of wounds. Several patents have been awarded and more are pending in the U.S. and internationally.

The Terrasil Wound Care Ointment can be purchased direct from the company at http://www.AidanceProducts.com or by calling 877-424-3262. Medical professionals interested in learning more about Terrasil Wound Care Ointment, click here.

About Aidance Skincare

Aidance Skincare is a Woonsocket, Rhode Island based company that provides natural, therapeutic skincare solutions to physicians and customers in more than 150 countries. The companys research of all-natural skin treatments spans 10 years and has yielded remarkable discoveries; most notably, Activated Minerals (multiple international patents issued and pending). Aidance prides itself on offering products that are based on proven science and actual customer success. For more information, contact Aidance Skincare at 877-424-3262 or visit http://www.AidanceProducts.com.

About Aspiera Medical

Aspiera Medical is a division of Aidance Skincare that works in collaboration with physicians and researchers. Aspiera is rooted in more than 10 years of research and product development. It exists to offer the medical community products to support faster healing for bacterial skin infections, wounds, fungal infections, and warts. For more information, please visit http://www.Aspiera.com or contact David Goldsmith at david(at)aspiera(dot)com, or 401-400-0047.

LASIO

New York, NY (PRWEB) November 20, 2012

LASIO

Axia Medical, Keraplast Technologies to Offer Keras Skin Care System to U.S. Physicians

Carlsbad, CA (PRWEB) April 11, 2013

Keraplast Technologies and Axia Medical announced today an exclusive partnership to bring the Keras skin care system to U.S. dermatologists, plastic surgeons, spas and clinics under physician direction.

Incorporating the latest advancements in wound treatment, the Keras system uses the proven Replicine Functional Keratin

hCGTreatments / Diet Doc hCG Diets and Weight Loss Plans Offers Dieters 100% prescription grade hCG, manufactured in the U.S. in strict compliance with the FDA

Billings, MT (PRWEB) April 03, 2013

Choosing the perfect diet can sometimes become cumbersome and confusing. Diet Docs prescription hCG diet plan offers dieters a simple solution to fast weight loss. Diet Doc offers only pure prescription grade hCG treatments with their medically supervised diet plans, providing safe and effective results unlike other non-pure hCG treatments. With any one internet search revealing hundreds of diets and the availability of diet aids in most drugstores and variety stores, choosing the perfect diet can sometimes become very confusing. When choosing a diet, the dieter should feel comfortable that the diet plan will not cause any unpleasant health effects and fits comfortably into ones lifestyle.

Experts agree that losing as little as 10-20 pounds can improve ones health exponentially. Diet Doc has developed a diet plan that works for those who desire to lose only 10 pounds to those who need to lose 100 pounds or more. Pure prescription hCG, when combined with their patient specific diet plan, is proven to produce safe and fast weight loss. In fact, 97% of Diet Doc clients proclaim results of up to one pound per day of unwanted, unhealthy excess fat. The company's certified nutritionists work diligently to develop a diet plan customized to each clients individual needs, as well as providing a cookbook filled with healthy and delicious recipes and only ure prescription hCG treatments.

When choosing to lose weight fast using prescription hCG diet plan, clients must first complete a health questionnaire detailing medical history, age, gender and lifestyle, as well as anticipated weight loss goals. When the dieter is deemed an acceptable hCG candidate, weight loss physicians will prescribe hCG in either injectable form, which is the preferred method due to its ability to produce the best weight loss, sublingual tablets, or oral hCG drops. Regardless of the method of delivery, Diet Doc clients can anticipate healthy and safe results. The company also offers a comprehensive and successful collection of prescription and non-prescription vitamins, minerals and weight loss accelerants to complement the prescription hCG diet plan. Diet Doc prescription hCG patients are guaranteed a proven effective weight loss experience provided the patient adheres to the customized diet program.

Diet Docs goal is to provide each patient with the safest, highest quality product available on the market. The company's manufacturer, located in the U.S, produces only 100% prescription grade hCG injection or oral tablet medication. The highest quality standards for the manufacturing of all of prescription required medications and supplements are implemented and are in strict accordance with the Food and Drug Administration. Diet Doc has become the Nations leader in doctor designed and physician monitored prescription hCG diet plans and has provided safe and fast weight loss to thousands of Americans for over a decade. At a fraction of the cost of expensive and often risky alternatives, Diet Doc has pricing plans available to fit even the tightest budget, making losing weight affordable to almost anyone. Each patients diet journey is monitored by in-house professional healthcare experts who are available 6 days per week to lend unlimited support, guidance and encouragement for up to one year to assure that each patient enjoys a safe and successful dieting experience.

Contact Diet Doc:

1-888-934-4451

Weight Loss Market in U.S. Up 1.7% to $61 Billion

Tampa, FL (PRWEB) April 16, 2013

Marketdata Enterprises, Inc., a leading independent market research

publisher of off-the-shelf studies about service industries since 1979, has released its biennial 420-page study: The U.S. Weight Loss & Diet Control Market (12th edition). This is a complete analysis and forecast of ALL ten major segments of the U.S. diet market.

Americas estimated 108 million dietersabout 82% of whom try to lose weight by themselves, are hunkering down. The new diet season, which starts January 1st and ends around Memorial Day, is off to a slow start this year. First, none of the major diet companies has anything that compelling or radically new. Secondly, we have a very weak economy, high gas prices and rising payroll taxes. Bad winter weather and many snowstorms in the Midwest and Northeast didnt help weight loss center attendance either. Celebrity endorsements can go only so far in this environment., according to Research Director, John LaRosa.

.

Major Report Findings:

Market Size

Marketdata estimates that the total U.S. weight loss market grew just 1.7% in 2012, as most market segments were flat or marginally up. Revenues were $ 61.6 billion in 2012, and $ 60.6 billion in 2011, (up 3.8% from $ 58.4 billion in 2010). Revenues are forecast to grow 2.6% in 2013.

Do-it-yourself Dieters

Dieters shifted toward greater use of free and low-cost do-it-yourself diet plans, (diet websites, OTC diet pills, meal replacements and diet books). Marketdata finds that the share of dieters that prefer a self-directed program is now 82% during 2012 near the highest ever. Historically since 1989, about 70% of dieters have used a self-directed plan, but this share has risen due to the last recession.

Commercial weight loss chains

Sales by all commercial weight loss centers were flat in 2012no growth. Marketdata analysts estimate this segment at $ 3.42 billion, and we expect 2.7% average annual growth to 2016. Weight Watchers and NutriSystem revenues were flat in 2012, while Medifast was up and Jenny Craig declined to an estimated $ 343 million.

MLM Rules As A Sales Method

Multi-level marketing has emerged as the growth engine for weight loss companies--Not franchising--Not adding more company-owned centers. This non-traditional method of selling via hundreds of thousands of independent contractors or distributors, is working extremely well for a few companies. Herbalife, surprisingly, is now the #2 weight loss company in the United States. The company posted North American weight loss product sales of $ 529 million in 2012, up 21%. Medifast sales reached a new high of $ 357 million last year and 65% of this was related to its Take Shape For Life MLM division. Visalis Sciences, another MLM company, saw its sales of meal replacements rise five-fold in 2011, to $ 220 million in wholesale sales.

Diet Drugs

No blockbusters yet. Large drug companies and the medical community are realizing that developing an effective diet drug with no significant side effects and weight loss in excess of 5% of body weight is more difficult than they thought. Qsymia sales started out very slow in the 4th quarter of 2012 and should increase in 2013, but Marketdata does not expect much of an impact on dieter behavior or competitors from this drug, or from Belviq, slated to enter the market in the coming months.

Untapped Niche Markets

American diet companies will seek to boost revenues by looking at untapped or under-tapped markets and niches, such as: the mens market, teen market, African-American and Hispanic markets, the diabetic market, the elderly market, the $ 859 million worksite-based B2B market, and the $ 6 billion Canadian market.

Retail Diet Pills & Meal Replacements

The weak economy and tighter consumer weight loss budgets definitely helped this do-it-yourself category. Dieters are attracted by the low price and easy availability. Marketdata estimates that the combined sales of diet pills and meal replacements was up about 2% to $ 2.78 billion last year. To 2016, Marketdata forecasts 6% annual gains in sales. The strong momentum is now with meal replacements (shakes, nutrition bars) not OTC diet pills. Meal replacements are safer for producers no ingredients that cause side effects. They can also be easily private labeled.

Diet Websites

Online dieting is worth at least $ 1.1 billion, by our estimates, and is growing 8% per year. Most sites are not profitable and are moving to a user-free, ad-supported model. WeightWatchers.com is #1, with 1.7 million paid subscribers and 2012 revenue of $ 504 million.

Weight Loss Surgeries

The number of bariatric surgeries is significantly less than reported by the ASMBS (bariatric surgeons national society). Surgeries peaked at 135,000 in 2008, according to government healthcare agency data (not 209,000 reported by the ASMBS). However, since then, insurers have gotten tougher on coverage and the number has fallen 15% to an estimated 114,000 last year. This reduced the size of the total weight loss market by $ 2.6 billion and translated into less business for bariatricians and VLCD programs.

Diet Food Home Delivery Services

This is an $ 858 million segment of the weight loss market that has declined 7.5% from 2009 levels. NutriSystem captures 46% of sales, but has suffered five consecutive years of declining sales. 2011-2012 continued to be challenging years for all diet food delivery services. Four of them went out of business. Even NutriSystem, which is priced at the low end of $ 250-$ 300/month, felt the effects of the recession, cut prices and offered weeks of free food for auto-ship clients. The share of dieters that wants diet food delivery averaged 5.8% over the past eight years, but that fell to 4.5% in 2012.

Flat is the new growth, as the U.S. weight loss market grew less than 2% in 2012. The U.S. diet market is entering a new era of slow growth, until the economy truly strengthens. Diet companies must find untapped niches, sharpen their marketing, and offer consumers a variety of programs at different price points to compete and survive. Theyll also need to use alternative distribution channels, such as: MLM, retail healthcare mini-clinics, shopping malls, OB/gyn offices, etc., according to John LaRosa.

ABOUT THE REPORT

The U.S. Weight Loss & Diet Control Market, published in March 2013, is an independently researched off-the-shelf study. The study is 420 pages in length and contains 160 tables/charts and 30+ in-depth competitor profiles. It costs $ 2,295 and is also sold by individual chapters at lower cost. Available in digital or print format. Free table of contents is available by mail, email or fax. Contact: Marketdata Enterprises, Inc., Regents Park Drive, Suite 120, Tampa, FL 33647, (813) 907-9090. John LaRosa is available for interviews. A 40 pp. Overview of major findings is available to the public for $ 99, at: http://www.marketdataenterprises.com.

ABOUT MARKETDATA

Marketdata is a 34-year old independent market research publisher and consulting firm, specializing in service and healthcare sectors. The firm publishes off-the-shelf multi-client market and industry studies, performs custom research and consulting. Mr. LaRosa is available for interviews, and performs teleconferences, and has tracked the weight loss market for 24 years. Other Marketdata websites include: BestDietForme.com and DietBusinessWatch.com. Other weight loss studies available for: Diet Websites Market, How To Run A Weight Loss Business, the Diet Food Delivery Market, and Quarterly Online Dieter trend Reports.

Related Weight Loss Diet Press Releases